Cancer Research UK logo.
SearchDonate
  • Search

A trial of MK-7684A and chemotherapy for small cell lung cancer (KeyVibe-008)

Overview

Cancer types:

Lung cancer, Secondary cancers, Small cell lung cancer

Status:

Closed

Phase:

Phase 3

Details

This trial is looking at a new drug called MK-7684A with chemotherapy to treat small cell lung cancer.

It is for people whose cancer has spread within the chest or to other parts of the body. This is called extensive disease.

Recruitment start: 28 September 2022

Recruitment end: 2 June 2023

How to join

Please note: In order to you will need to discuss it with your doctor, unless otherwise specified.

Chief investigators

Dr Raffaele Califano

Supported by

Merck Sharp & Dohme LLC

Last reviewed: 01 Jun 2023

CRUK internal database number: 18361

Help and support